RichardDKimMD

PubMed

• Prevention and treatment of FGFR inhibitor-associated toxicities.
  Mahipal, A., Tella, S. H., Kommalapati, A., Yu, J., Kim, R.> ;Critical reviews in oncology/hematology. 2020 Sep 23
• Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer
  Richard D. Kim, Nilofer S. Azad, Michael A. Morse, Elizabeth Poplin, Amit Mahipal, Benjamin R. Tan, Sharon A. Mavroukakis, Massimo Fantini, Kwong Y. Tsang, Anjum Zaki,...> ;Clinical Cancer Research. 2020 Jul 15
• A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer.
  Kim, R. D., Sanoff, H. K., Poklepovic, A. S., Soares, H., Kim, J., Lyu, J., Liu, Y., Nixon, A. B., Kim, D. W.> ;Cancer. 2020 May 27
• CT-based radiomic features to predict pathological response in rectal cancer: A retrospective cohort study.
  Yuan, Z., Frazer, M., Zhang, G. G., Latifi, K., Moros, E. G., Feygelman, V., Felder, S., Sanchez, J., Dessureault, S., Imanirad, I., Kim, R. D., Harrison, L. B., Hoffe...> ;Journal of medical imaging and radiation oncology. 2020 May 10
• A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer.
  Kim, R. D., Chung, V., Alese, O. B., El-Rayes, B. F., Li, D., Al-Toubah, T. E., Schell, M. J., Zhou, J., Mahipal, A., Kim, B. H., Kim, D. W.> ;JAMA oncology. 2020 May 1
• Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer
  Richard D. Kim, Shannon McDonough, Anthony B. El-Khoueiry, Tanios Bekaii-Saab, Stacey M. Stein, Vaibhav Sahai, George P. Keogh, Edward J. Kim, Ari David Baron, Abby B....> ;European Journal of Cancer. 2020 May 1
• EM-mosaic detects mosaic point mutations that contribute to congenital heart disease.
  Hsieh, A., Morton, S. U., Willcox, J. A., Gorham, J. M., Tai, A. C., Qi, H., DePalma, S., McKean, D., Griffin, E., Manheimer, K. B., Bernstein, D., Kim, R. W., Newburg...> ;Genome medicine. 2020 May 1
• Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation.
  Frazer, M. L., Yang, G., Felder, S., McDonald, J., Sanchez, J., Dessureault, S., Imanirad, I., Carballido, E., Kim, R. D., Hoffe, S. E., Frakes, J. M.> ;American journal of clinical oncology. 2020 Feb 7
• Acquired On-Target Clinical Resistance Validates FGFR4 as a Driver of Hepatocellular Carcinoma.
  Hatlen, M. A., Schmidt-Kittler, O., Sherwin, C. A., Rozsahegyi, E., Rubin, N., Sheets, M. P., Kim, J. L., Miduturu, C., Bifulco, N., Brooijmans, N., Shi, H., Guzi, T.,...> ;Cancer discovery. 2019 Oct 3
• First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.
  Kim, R. D., Sarker, D., Meyer, T., Yau, T., Macarulla, T., Park, J., Choo, S. P., Hollebecque, A., Sung, M. W., Lim, H., Mazzaferro, V., Trojan, J., Zhu, A. X., Yoon, ...> ;Cancer discovery. 2019 Oct 3
• Partial Splenic Artery Embolization in 35 Cancer Patients: Results of a Single Institution Retrospective Study.
  Kis, B., Mills, M., Smith, J., Choi, J., Sagatys, E., Komrokji, R., Strosberg, J., Kim, R. D.> ;Journal of vascular and interventional radiology : JVIR. 2019 Sep 1
• Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
  Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, Alexander Lim, Richard B. Kim> ;Cancers. 2019 Jul 30
• FGFR2 genomic aberrations: Achilles heel in the management of advanced cholangiocarcinoma.
  Amit Mahipal, Sri Harsha Tella, Anuhya Kommalapati, Daniel A. Anaya, Richard B. Kim> ;Cancer Treatment Reviews. 2019 Jun 22
• Structural network topology correlates of microstructural brain dysmaturation in term infants with congenital heart disease
  Vincent J. Schmithorst, Jodie K. Votava-Smith, Nhu Tran, Richard W. Kim, Vince Lee, Rafael Ceschin, Hollie Lai, Jennifer A. Johnson, Joan Sanchez De Toledo, Stefan Blu...> ;Human Brain Mapping. 2018 Nov 1
• The Role of Angiogenesis in Hepatocellular Carcinoma.
  Morse, M. A., Sun, W., Kim, R., He, A. R., Abada, P. B., Mynderse, M., Finn, R. S.> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Oct 3
• Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer
  Hanna K. Sanoff, Richard M. Goldberg, Anastasia Ivanova, Seamus O'Reilly, Samer S. Kasbari, Richard D. Kim, Ray McDermott, Dominic T. Moore, William C. Zamboni, Willia...> ;Cancer. 2018 Aug 1
• Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors.
  Puri, S.,Hyland, K. A.,Weiss, K. C.,Bell, G. C.,Gray, J. E.,Kim, R.,Lin, H. Y.,Hoogland, A. I.,Gonzalez, B. D.,Nelson, A. M.,Kinney, A. Y.,Fischer, S. M.,Li, D.,Jacobs...> ;Support Care Cancer. 2018 Mar 17
• Novel targeted treatment options for advanced cholangiocarcinoma.
  Mahipal, A.,Kommalapati, A.,Tella, S. H.,Lim, A.,Kim, R.> ;Expert Opin Investig Drugs. 2018 Aug 21
• Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.
  Gangi, A., Shah, J., Hatfield, N., Smith, J., Sweeney, J., Choi, J., El-Haddad, G., Biebel, B., Parikh, N., Arslan, B., Hoffe, S. E., Frakes, J. M., Springett, G. M., ...> ;Journal of vascular and interventional radiology : JVIR. 2018 Jul 26
• Viral hepatitis associated hepatocellular carcinoma outcomes with yttrium-90 radioembolization.
  Frakes, J. M., Abuodeh, Y. A., Naghavi, A. O., Echevarria, M. I., Shridhar, R., Friedman, M., Kim, R., El-Haddad, G., Kis, B., Biebel, B., Sweeney, J., Choi, J., Anaya...> ;Journal of gastrointestinal oncology. 2018 Jul 13
• Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma.
  Kim, R., Coppola, D., Wang, E., Chang, Y. D., Kim, Y., Anaya, D. A., Kim, D. W.> ;Oncotarget. 2018 May 29
• A Guide for Understanding Health Education and Promotion Programs.
  Richard W. Kim, Vinayak K. Nahar> ;Health Promotion Practice. 2018 Mar 1
• Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.
  Richard D. Kim, Steven R. Alberts, Carol Peña, Isabelle Genvresse, A. Ajavon-Hartmann, Chenghua Xia, Andrea Kelly, Juneko E. Grilley-Olson> ;British Journal of Cancer. 2018 Feb 20
• 1 citation
  The Congenital Heart Disease Genetic Network Study: Cohort description.
  Hoang, T. T., Goldmuntz, E., Roberts, A. E., Chung, W. K., Kline, J. K., Deanfield, J. E., Giardini, A., Aleman, A., Gelb, B. D., Neal, M. M., Porter, G. A., Kim, R., ...> ;PloS one. 2018 Jan 20
• Single Institute Experience With Methylphenidate and American Ginseng in Cancer-Related Fatigue.
  Young D. Chang, Joshua Smith, Diane Portman, Richard D. Kim, Ritika Oberoi-Jassal, Sahana Rajasekhara, Mellar P. Davis> ;American Journal of Hospice and Palliative Medicine. 2018 Jan 1
• Join now to see all

Lectures

• A phase II study of nivolumab in patients with advanced refractory biliary tract cancers (BTC). 
  2019 ASCO Annual Meeting - 6/1/2019